92
Views
12
CrossRef citations to date
0
Altmetric
Original Research

Predictive Models for HCC Prognosis, Recurrence Risk, and Immune Infiltration Based on Two Exosomal Genes: MYL6B and THOC2

, , , , , , , , ORCID Icon, , , , , & ORCID Icon show all
Pages 4089-4109 | Published online: 24 Aug 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Xuan-Hai Do, Mai Thi Le, Thu Huyen Nguyen, Thanh Thien Le, Xuan-Hung Nguyen, Thanh Binh Mai, Thi My Nhung Hoang & Uyen Thi Trang Than. (2023) Detection of sFas, sCD137, and IL-27 Cytokines as Potential Biomarkers for Hepatocellular Carcinoma Diagnosis. Journal of Hepatocellular Carcinoma 10, pages 783-793.
Read now
Dongdong Xue, Jingzhao Han, Ze Liang, Lin Jia, Yifan Liu, Hongfang Tuo & Yanhui Peng. (2022) Current Perspectives on the Unique Roles of Exosomes in Drug Resistance of Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma 9, pages 99-112.
Read now
Xixi Li, Zefeng Liu, Xin Wei, Jie Lin, Qiwei Yang & Yingjun Xie. (2022) Comprehensive Analysis of the Expression and Clinical Significance of THO Complex Members in Hepatocellular Carcinoma. International Journal of General Medicine 15, pages 2695-2713.
Read now
Yinghui Zhu, Dezhi Shan, Lianyi Guo, Shujia Chen & Xiaofei Li. (2022) Immune-Related lncRNA Pairs Clinical Prognosis Model Construction for Hepatocellular Carcinoma. International Journal of General Medicine 15, pages 1919-1931.
Read now

Articles from other publishers (8)

Bufu Tang, Yajie Wang, Jinyu Zhu, Jingjing Song, Shiji Fang, Qiaoyou Weng, Yang Yang, Jianfei Tu, Zhongwei Zhao, Minjiang Chen, Min Xu, Weiqian Chen & Jiansong Ji. (2023) TACE responser NDRG1 acts as a guardian against ferroptosis to drive tumorgenesis and metastasis in HCC. Biological Procedures Online 25:1.
Crossref
Lei Zhao, Zhixuan You, Zhixun Bai & Jian Xie. (2023) Machine learning-based construction of a ferroptosis and necroptosis associated lncRNA signature for predicting prognosis and immunotherapy response in hepatocellular cancer. Frontiers in Oncology 13.
Crossref
Zhan Yang, Xinmiao Li, Chaoran Pan, Yifei Li, Lifan Lin, Yan Jin, Jianjian Zheng & Zhengping Yu. (2022) A comprehensive study based on exosome-related immunosuppression genes and tumor microenvironment in hepatocellular carcinoma. BMC Cancer 22:1.
Crossref
Li Song, Qiankun Li, Yao Lu, Xianqi Feng, Rungong Yang & Shouguo Wang. (2022) Cancer Progression Mediated by CAFs Relating to HCC and Identification of Genetic Characteristics Influencing Prognosis. Journal of Oncology 2022, pages 1-16.
Crossref
Bao-Wen Tian, Cheng-Long Han, Zhao-Ru Dong, Si-Yu Tan, Dong-Xu Wang & Tao Li. (2022) Role of Exosomes in Immunotherapy of Hepatocellular Carcinoma. Cancers 14:16, pages 4036.
Crossref
Dian Xia, Qi Liu, Songbai Yan & Liangkuan Bi. (2022) Construction of a Prognostic Model for KIRC and Identification of Drugs Sensitive to Therapies - A Comprehensive Biological Analysis Based on m6A-Related LncRNAs. Frontiers in Oncology 12.
Crossref
Chuzhi Shang, Mi Ke, Lin Liu, Cong Wang, Yufang Liu & Xin Zheng. (2022) Exosomes From Cancer-Associated Mesenchymal Stem Cells Transmit TMBIM6 to Promote the Malignant Behavior of Hepatocellular Carcinoma via Activating PI3K/AKT Pathway. Frontiers in Oncology 12.
Crossref
Xiaojun Jin, Yongfei Song, Zhanglu An, Shanshan Wu, Dihui Cai, Yin Fu, Chuanjing Zhang, Lichao Chen, Wen Tang, Zequn Zheng, Hongsheng Lu & Jiangfang Lian. (2022) A Predictive Model for Prognosis and Therapeutic Response in Hepatocellular Carcinoma Based on a Panel of Three MED8-Related Immunomodulators. Frontiers in Oncology 12.
Crossref